Add Company
Join Now

Vivasc Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vivasc Therapeutics's estimated annual revenue is currently $201k per year.(i)
  • Vivasc Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Vivasc Therapeutics has 2 Employees.(i)
  • Vivasc Therapeutics grew their employee count by 0% last year.

Vivasc Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Vivasc Therapeutics?

Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various cargo exclusively to cardiomyocytes in a non-invasive manner. We are actively seeking: Joint development partners for our lead compound, CTP-amio, for the treatment of arrhythmias (atrial fibrillation and ventricular tachycardia) Partners to use CTP as a platform vector to deliver other therapeutic cargo (oligonucleotides, peptides, proteins, drugs, nanoparticles, stem cell therapies, etc.) exclusively to cardiomyocytes

keywords:N/A

N/A

Total Funding

2

Number of Employees

$201k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M2-33%N/A
#2
N/A2-94%N/A
#3
$0.1M20%N/A
#4
$0.2M2-33%N/A
#5
$7.5M2-33%N/A